Prana Doses 1st Patient in PBT2 Alzheimers Extension Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
Later from Alterity Therapeutics
- Appendix 4C - Quarterly report
- Appendix 4E - Preliminary Financial Report
- First Patient Enrolled in Phase II Huntington Disease Trial
- Prana Comments on Neurology Publication Huntington Data
- Prana Doses First Patient in the IMAGINE Phase II Trial
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics